搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
tars
/
财务摘要
Tarsus Pharmaceuticals Inc
TARS
添加自选
64.790
USD
-0.540
-0.83%
收盘 08-07 16:00(美东)
报价延迟15分钟
USD
0.000
盘后交易 (美东)
2.79B
总市值
亏损
市盈率 TTM
Tarsus Pharmaceuticals Inc
64.790
-0.540
-0.83%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
TARS 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Tarsus Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
Tarsus Pharmaceuticals Inc 财报日历
最新发布
8月 6, 2026
每股收益 / 预测值
-0.43
/-0.20
营业收入 / 预测值
173.91M
/169.68M
查看即将公布的财报 >>
报告期
FY2025 财报
营业收入(YoY)
451.36M
146.71%
每股收益(YoY)
-1.59
48.27%
分析师评级
STRONG BUY
2026/08/07
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
10.45%
-0.43
74.60%
-0.16
67.34%
-0.20
51.59%
-0.30
45.45%
-0.48
36.92%
-0.64
52.31%
-0.60
52.27%
-0.61
24.89%
-0.88
-15.58%
-1.01
-146.86%
-1.26
--
-1.28
--
-1.17
--
-0.88
--
-0.51
--
-2.03
--
--
--
--
--
--
--
--
营业收入
69.41%
173.91M
106.87%
162.05M
128.39%
151.67M
146.68%
118.70M
151.54%
102.66M
183.68%
78.33M
407.86%
66.41M
2471.78%
48.12M
--
40.81M
1004.56%
27.61M
30.76%
13.08M
--
1.87M
-100.00%
0.00
363.82%
2.50M
2858.58%
10.00M
-100.00%
0.00
-30.61%
15.28M
-98.39%
539.00K
--
338.00K
--
1.24M
净利润
--
--
72.27%
-6.97M
63.77%
-8.37M
46.26%
-12.59M
38.90%
-20.34M
29.70%
-25.12M
44.84%
-23.11M
40.18%
-23.42M
-5.94%
-33.29M
-52.57%
-35.73M
-208.13%
-41.90M
-73.91%
-39.15M
-447.17%
-31.42M
-15.72%
-23.42M
8.39%
-13.60M
-43.41%
-22.51M
-191.17%
-5.74M
-296.75%
-20.24M
-29.45%
-14.84M
-54.83%
-15.70M
利润率
--
--
86.59%
-4.30%
84.14%
-5.52%
78.22%
-10.60%
75.71%
-19.81%
75.22%
-32.07%
89.14%
-34.80%
97.67%
-48.67%
--
-81.57%
86.19%
-129.39%
-135.64%
-320.45%
--
-2092.36%
--
--
--
-936.76%
--
-135.99%
--
-306.60%
--
--
--
--
--
--
--
--
毛利率
-0.95%
93.03%
0.91%
94.20%
0.23%
92.80%
-0.28%
93.00%
1.39%
93.92%
-0.70%
93.35%
2.07%
92.58%
16.80%
93.26%
--
92.64%
-5.99%
94.01%
-5.52%
90.70%
--
79.85%
--
--
--
100.00%
--
96.00%
--
96.49%
--
--
--
--
--
--
--
--
资产负债率
-18.29%
11.91%
-13.10%
12.49%
-32.39%
12.89%
-29.04%
13.52%
-23.28%
14.57%
67.74%
14.38%
69.68%
19.06%
72.12%
19.06%
45.83%
18.99%
-26.16%
8.57%
31.69%
11.23%
--
11.07%
--
13.02%
--
11.61%
--
8.53%
--
8.19%
--
--
--
--
--
--
--
--
利润表
营业收入
69.41%
173.91M
106.87%
162.05M
128.39%
151.67M
146.68%
118.70M
151.54%
102.66M
183.68%
78.33M
407.86%
66.41M
2471.78%
48.12M
--
40.81M
1004.56%
27.61M
30.76%
13.08M
--
1.87M
-100.00%
0.00
363.82%
2.50M
2858.58%
10.00M
-100.00%
0.00
-30.61%
15.28M
-98.39%
539.00K
--
338.00K
--
1.24M
营业利润
10.26%
-19.91M
76.70%
-6.12M
67.34%
-7.98M
42.26%
-14.53M
33.39%
-22.18M
30.26%
-26.28M
45.06%
-24.42M
38.53%
-25.16M
-1.47%
-33.30M
-51.03%
-37.68M
-195.13%
-44.45M
-78.71%
-40.94M
-528.27%
-32.82M
-27.82%
-24.95M
-4.24%
-15.06M
-45.85%
-22.91M
-171.74%
-5.22M
-282.20%
-19.52M
-25.89%
-14.45M
-54.87%
-15.71M
净利润
--
--
72.27%
-6.97M
63.77%
-8.37M
46.26%
-12.59M
38.90%
-20.34M
29.70%
-25.12M
44.84%
-23.11M
40.18%
-23.42M
-5.94%
-33.29M
-52.57%
-35.73M
-208.13%
-41.90M
-73.91%
-39.15M
-447.17%
-31.42M
-15.72%
-23.42M
8.39%
-13.60M
-43.41%
-22.51M
-191.17%
-5.74M
-296.75%
-20.24M
-29.45%
-14.84M
-54.83%
-15.70M
资产负债表
流动资产
18.46%
561.99M
11.74%
537.23M
46.56%
522.78M
40.49%
501.70M
30.85%
474.43M
41.10%
480.77M
39.27%
356.70M
37.74%
357.12M
97.62%
362.59M
63.30%
340.72M
13.65%
256.13M
10.77%
259.28M
-26.69%
183.48M
16.72%
208.65M
28.09%
225.38M
25.12%
234.08M
24.58%
250.28M
-6.63%
178.75M
3.10%
175.95M
110.04%
187.09M
流动负债总额
94.73%
175.75M
66.27%
143.51M
68.33%
135.69M
77.70%
117.05M
75.01%
90.25M
102.94%
86.31M
118.25%
80.61M
183.32%
65.87M
249.28%
51.57M
220.84%
42.53M
139.39%
36.94M
62.89%
23.25M
26.00%
14.77M
5.11%
13.26M
34.42%
15.43M
37.70%
14.27M
12.08%
11.72M
24.63%
12.61M
113.07%
11.48M
68.70%
10.37M
总资产
23.46%
611.14M
16.05%
581.13M
49.12%
562.16M
42.06%
534.56M
31.35%
494.99M
43.37%
500.75M
42.00%
376.99M
40.24%
376.30M
99.47%
376.84M
65.37%
349.28M
16.51%
265.49M
13.48%
268.33M
-25.27%
188.93M
16.38%
211.21M
27.36%
227.86M
24.19%
236.47M
24.27%
252.83M
-6.43%
181.48M
4.03%
178.91M
106.55%
190.41M
总负债
62.83%
264.41M
46.68%
232.18M
43.47%
218.73M
43.70%
199.48M
30.32%
162.38M
113.71%
158.29M
122.56%
152.46M
153.93%
138.82M
202.44%
124.60M
95.89%
74.07M
95.93%
68.50M
61.56%
54.67M
31.53%
41.20M
17.11%
37.81M
187.12%
34.96M
200.25%
33.84M
185.30%
31.32M
201.12%
32.29M
103.22%
12.18M
64.41%
11.27M
总权益
4.25%
346.73M
1.90%
348.95M
52.95%
343.43M
41.10%
335.08M
31.86%
332.61M
24.43%
342.46M
13.98%
224.53M
11.15%
237.48M
70.75%
252.25M
58.71%
275.21M
2.12%
196.99M
5.45%
213.66M
-33.31%
147.73M
16.22%
173.40M
15.70%
192.90M
13.11%
202.63M
15.08%
221.50M
-18.57%
149.20M
0.45%
166.73M
109.94%
179.14M
现金流量表
经营净额
308.33%
61.22M
-19.37%
-24.65M
187.14%
19.33M
311.01%
18.26M
-104.02%
-29.39M
45.35%
-20.65M
43.61%
-22.18M
73.26%
-8.65M
39.55%
-14.40M
-72.00%
-37.79M
-261.73%
-39.34M
-73.89%
-32.36M
-459.43%
-23.83M
-43.73%
-21.97M
10.29%
-10.87M
-361.68%
-18.61M
-120.72%
-4.26M
-29.61%
-15.29M
-21.05%
-12.12M
208.22%
7.11M
投资净额
173.26%
37.88M
-67.60%
-58.56M
182.71%
49.27M
-251.63%
-4.74M
-27.59%
-51.70M
65.82%
-34.94M
-433.75%
-59.57M
-93.40%
3.13M
-163.23%
-40.52M
-1005.12%
-102.22M
120.47%
17.85M
182.92%
47.37M
52634.43%
64.09M
7114.91%
11.29M
-31731.75%
-87.22M
-47112.40%
-57.13M
-662.50%
-122.00K
8.00%
-161.00K
-648.00%
-274.00K
10.37%
-121.00K
融资净额
69.16%
3.30M
-99.12%
1.20M
-21.01%
2.31M
300.94%
2.56M
-95.39%
1.95M
25.55%
136.56M
-85.19%
2.93M
-99.39%
639.00K
8197.84%
42.32M
2069.78%
108.77M
7384.85%
19.76M
77227.21%
104.89M
-99.32%
510.00K
-73.79%
5.01M
456.76%
264.00K
-281.33%
-136.00K
7473300.00%
74.73M
100557.89%
19.13M
-100.08%
-74.00K
-99.81%
75.00K
常见问题
Tarsus Pharmaceuticals Inc的总收入是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,总收入达到了451.36M(同比变化182.95M)。
Tarsus Pharmaceuticals Inc的流动资产是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,流动资产为522.78M(同比变化46.56)。
Tarsus Pharmaceuticals Inc的总资产是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,Tarsus Pharmaceuticals Inc的总资产为562.16M(同比变化49.12)。
Tarsus Pharmaceuticals Inc的总负债是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,Tarsus Pharmaceuticals Inc的总负债为218.73M(同比变化43.47)。
Tarsus Pharmaceuticals Inc的总权益是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,Tarsus Pharmaceuticals Inc的总权益为343.43M(同比变化52.95)。
Tarsus Pharmaceuticals Inc的净营业收入是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,Tarsus Pharmaceuticals Inc的净营业收入为-70.97M(同比变化41.14)。
Tarsus Pharmaceuticals Inc的净投资是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,Tarsus Pharmaceuticals Inc的净投资为-42.12M(同比变化78.86)。
Tarsus Pharmaceuticals Inc的净融资是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,Tarsus Pharmaceuticals Inc的净融资为143.39M(同比变化-7.29)。
Tarsus Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-1.59(同比变化48.27)。
Tarsus Pharmaceuticals Inc的净利润是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,净利润为-66.42M(同比变化42.52)。
Tarsus Pharmaceuticals Inc的净利润率是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,净利润率为-14.72(同比变化76.70)。
Tarsus Pharmaceuticals Inc的毛利率是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,毛利率为93.20(同比变化0.23)。
Tarsus Pharmaceuticals Inc的债务与资产比率是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,债务与资产比率为12.89(同比变化-32.39)。
Tarsus Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-23.39(同比变化57.34)。
Tarsus Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-14.14(同比变化60.68)。
Tarsus Pharmaceuticals Inc的营业利润是多少?
根据Tarsus Pharmaceuticals Inc的FY2025财报,营业利润为-70.97M(同比变化41.14)。